Evidence map›Paper›PMID 41206009›Full record

ArticleEndocrinology2025

Forebrain AR Deletion Restores PR Expression but not Reproduction in Prenatally Androgenized Female Mice.

Emily E A Lott, Melanie Prescott, Kyoko Potapov, David J Handelsman, Kelly A Glendining, Rebecca E Campbell

Abstract read
In one paragraph

Article in Endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Emily E A LottCentre for Neuroendocrinology and Department of Physiology, School of Biomedical Sciences, University of Otago, Dunedin 9054, New Zealand.ORCID 0009-0009-0971-2278
Melanie PrescottCentre for Neuroendocrinology and Department of Physiology, School of Biomedical Sciences, University of Otago, Dunedin 9054, New Zealand.
Kyoko PotapovCentre for Neuroendocrinology and Department of Physiology, School of Biomedical Sciences, University of Otago, Dunedin 9054, New Zealand.
David J HandelsmanAndrology Department, ANZAC Research Institute, University of Sydney, Concord Hospital, New South Wales 2139, Australia.ORCID 0000-0002-4200-7476
Kelly A GlendiningCentre for Neuroendocrinology and Department of Physiology, School of Biomedical Sciences, University of Otago, Dunedin 9054, New Zealand.
Rebecca E CampbellCentre for Neuroendocrinology and Department of Physiology, School of Biomedical Sciences, University of Otago, Dunedin 9054, New Zealand.ORCID 0000-0002-0309-532X

Funding

University of Otago Master's Scholarship and the New Zealand Health Research Council
6 · The paper itself

Abstract

Prenatal androgen excess (PNA), an etiologic factor for polycystic ovary syndrome (PCOS), is implicated in programming long-term reproductive deficits in females such as anovulation, subfertility, and hyperandrogenism. Impaired steroid hormone feedback is a key neuroendocrine feature suspected to underpin the development of reproductive dysfunction in both clinical PCOS and in PNA mice exposed to dihydrotestosterone during late gestation. PNA is suspected to act in the brain to program the impaired sensitivity of the GnRH neuronal network to progesterone negative feedback, centrally dysregulating the hypothalamic-pituitary-ovarian axis controlling reproduction. To test the hypothesis that androgen-sensitive neurons mediate PNA programming, we generated PNA female mice with a neuron-specific deletion of androgen receptors (AR) (NeurARKO) using Cre-lox transgenics. Following confirmation of embryonic AR deletion, PNA NeurARKO females were reproductively phenotyped and assessed for changes in progesterone receptor expression in the brain. PNA-induced reproductive traits including delayed pubertal onset, acyclicity, altered ovarian morphology, and subfertility were not different between NeurARKO and wild-type mice. In contrast, downregulation of progesterone receptor expression in PNA wild-type mice was protected against in PNA NeurARKO mice. Together, these findings suggest that although neuronal AR may contribute to PCOS-like impaired sensitivity to progesterone feedback, their deletion alone is insufficient to rescue reproductive dysfunction associated with PCOS.

Indexed as

Prenatal Exposure Delayed EffectsProsencephalonReceptors, AndrogenReceptors, ProgesteroneReproductionAndrogensAnimalsFemaleMiceMice, KnockoutMice, TransgenicPolycystic Ovary SyndromePregnancyAndrogensAR protein, mouseReceptors, AndrogenReceptors, Progesteroneandrogen receptorPCOSprenatal androgenprogesterone receptorreproduction

Identifiers

PMID41206009
PMCPMC12666388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.